GlassScriptPhysician profile
Ricardo A Leano
NPI 1689642993
$2,019.25
in general payments reported to CMS, 2019-2025
23 companies · $472 in 2025
The $472 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $56.72 · 2021: $113 · 2022: $681 · 2023: $235 · 2024: $339 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907 · Travel and Lodging: $113 · Education: $25.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.20 |
| Travel and Lodging | $113.28 |
| Education | $25.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $480.28 | 2022-2024 | Senza |
| Heron Therapeutics, INC. | $240.18 | 2022-2025 | Aponvie |
| Vertos Medical, INC. | $201.67 | 2022-2024 | Mild Device Kit |
| Boston Scientific Corporation | $189.68 | 2022-2025 | Farapulse |
| Globus Medical, INC. | $135.49 | 2025 | Senza, Vyrsa V1 |
| La Jolla Pharmaceutical Company | $121.84 | 2024 | Giapreza |
| Medtronic, INC. | $89.81 | 2023 | Intellis Adaptivestim |
| Forte Bio-Pharma LLC | $78.95 | 2019-2021 | |
| Spinal Simplicity, LLC | $76.63 | 2023-2025 | Ha Minuteman G3-R |
| Curonix LLC | $62.16 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Merck Sharp & Dohme LLC | $55.24 | 2020-2022 | |
| Stimwave Technologies Incorporated | $50.27 | 2020-2022 | |
| Virtus Pharmaceuticals LLC | $41.55 | 2021 | |
| Abbott Laboratories | $37.56 | 2019 | |
| Bioventus LLC | $24.99 | 2023 | Stimrouter Implantable Kit |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $21.88 | 2019 | |
| Masimo Corporation | $21.55 | 2023 | Sedline |
| Interventional Pain Technologies INC. | $20.46 | 2022 | |
| Zyla Life Sciences, INC. | $16.92 | 2019 | |
| Biodelivery Sciences International, INC. | $14.05 | 2021 | |
| Pfizer INC. | $13.67 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.29 | 2022 | |
| Collegium Pharmaceutical, INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricardo Leano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.